Cargando…
Vaccine therapy for dysbiosis-related diseases
Progress in genomic analysis has resulted in the proposal that the intestinal microbiota is a crucial environmental factor in the development of multifactorial diseases, such as obesity, diabetes, rheumatoid arthritis, and inflammatory bowel diseases represented by Crohn’s disease and ulcerative col...
Autores principales: | Fujimoto, Kosuke, Uematsu, Satoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7284185/ https://www.ncbi.nlm.nih.gov/pubmed/32550752 http://dx.doi.org/10.3748/wjg.v26.i21.2758 |
Ejemplares similares
-
Characterization of the human gut virome in metabolic and autoimmune diseases
por: Fujimoto, Kosuke, et al.
Publicado: (2022) -
Phage therapy for Clostridioides difficile infection
por: Fujimoto, Kosuke, et al.
Publicado: (2022) -
Ovariectomy-Induced Dysbiosis May Have a Minor Effect on Bone in Mice
por: Kosaka, Satoshi, et al.
Publicado: (2021) -
ggkegg: analysis and visualization of KEGG data utilizing the grammar of graphics
por: Sato, Noriaki, et al.
Publicado: (2023) -
High-fat diet-mediated dysbiosis exacerbates NSAID-induced small intestinal damage through the induction of interleukin-17A
por: Sugimura, Naoki, et al.
Publicado: (2019)